Remission achievable with usual care for axial spondyloarthritis
For patients with axial spondyloarthritis (axSpA), remission is attainable with usual care, according to a study published in the Journal of Rheumatology.
18 hours ago
0
5
Musculoskeletal Diseases: News and Research on Spondylarthritis
MeSH tree: C05.550.114.865
When should patients see a rheumatologist for chronic back pain?
Axial spondyloarthritis (axSpA) is an inflammatory condition that causes chronic back pain and, if left untreated, can lead to fusion of the spinal or sacroiliac joints. The condition frequently remains underdiagnosed, with ...
Sep 10, 2026
0
7
Socioeconomic status shapes treatment timing and duration in arthritis patients
A study initiated by the European Spondyloarthritis Research Collaboration Network (EuroSpA) examined whether patients' countries of residence are associated with the severity of their psoriatic arthritis (PsA) or axial spondyloarthritis ...
Aug 11, 2026
0
2
Bimekizumab well tolerated, efficacious over three years in axial spondyloarthritis
For patients with axial spondyloarthritis (axSpA), bimekizumab, a dual interleukin (IL)-17A and IL-17F inhibitor, is well tolerated over three years, according to a study published in the June issue of the Journal of Rheumatology.
Jul 9, 2026
0
7
Recommendations on physical activity in people with inflammatory arthritis or osteoarthritis
EULAR—the European Alliance of Associations for Rheumatology—has updated its recommendations on physical activity in people with inflammatory arthritis or osteoarthritis. These align with current World Health Organization ...
Apr 27, 2026
0
17
GLP-1 in joint fluid may let weight-loss drugs target arthritis directly
Arthritis includes a range of conditions that affect the joints, from inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis to more common conditions like osteoarthritis. Many people experience pain, ...
Apr 16, 2026
0
14
PEPITEM 'replacement therapy' shows potential for early-stage inflammatory arthritis
Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable to the current standard of care, and reduce the inflammatory changes that cause ...
Apr 13, 2026
0
21
Patients with psoriasis have elevated risk for complications after total hip arthroplasty
For patients undergoing total hip arthroplasty (THA), those with cutaneous psoriasis (PsC) and psoriatic arthritis (PsA) have an increased risk for complications, according to a study published online March 22 in the Journal ...
Mar 31, 2026
0
2
FDA approves Sotyktu for adults with active psoriatic arthritis
The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
Mar 11, 2026
0
7
How psoriasis affects joints: Researchers discover how inflammatory cells migrate from the skin
Approximately 20% to 30% of all people who suffer from psoriasis also develop painful inflammation in their joints over time. If left untreated, this condition known as psoriatic arthritis can lead to permanent damage to ...
Jan 14, 2026
0
27
